Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014 (2014), Article ID 301879, 12 pages
http://dx.doi.org/10.1155/2014/301879
Research Article

PASS-Predicted Hepatoprotective Activity of Caesalpinia sappan in Thioacetamide-Induced Liver Fibrosis in Rats

1Department of Anatomy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
2Department of Biomedical Science, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
3Department of Pharmacy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
4Nanotechnology & Catalysis Research Centre (NANOCAT), University of Malaya, Block 3A, Institute of Postgraduate Studies Building, 50603 Kuala Lumpur, Malaysia

Received 22 October 2013; Accepted 5 January 2014; Published 20 February 2014

Academic Editors: S. G. Clark, M. Pretterklieber, and M. Tsang

Copyright © 2014 Farkaad A. Kadir et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Ueki, Y. Kaneda, H. Tsutsui et al., “Hepatocyte growth factor gene therapy of liver cirrhosis in rats,” Nature Medicine, vol. 5, no. 2, pp. 226–230, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Munoz Torres, J. I. Paz Bouza, A. Lopez Bravo, M. M. Abad Hernandez, and E. Carrascal Marino, “Experimental thioacetamide-induced cirrhosis of the liver,” Histology and Histopathology, vol. 6, no. 1, pp. 95–100, 1991. View at Google Scholar · View at Scopus
  3. D. Schuppan and N. H. Afdhal, “Liver cirrhosis,” The Lancet, vol. 371, no. 9615, pp. 838–851, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Cassiman, C. Denef, V. J. Desmet, and T. Roskams, “Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors,” Hepatology, vol. 33, no. 1, pp. 148–158, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Reid, R. Muir, D. A. Levison, and A. D. Burt, Muir's Textbook of Pathology, Hodder Arnold, 2008.
  6. F. A. Kadir, N. M. Kassim, M. A. Abdulla, and W. A. Yehye, “Hepatoprotective role of ethanolic extract of vitex negundo in thioacetamide-induced liver fibrosis in male rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 739850, 9 pages, 2013. View at Publisher · View at Google Scholar
  7. S. Badami, S. Moorkoth, and B. Suresh, “Caesalpinia sappan—a medicinal and dye yielding plant,” Natural Product Radiance, vol. 3, pp. 75–82, 2004. View at Google Scholar
  8. J. Y. Lee and K. J. Min, “Antimicrobial activity and bactericidal activity of Caesalpinia sappan L. extract,” Hangug Hwangyeong Bogeon Haghoeji, vol. 37, pp. 133–140, 2011. View at Google Scholar
  9. O. Yodsaoue, S. Cheenpracha, C. Karalai, C. Ponglimanont, and S. Tewtrakul, “Anti-allergic activity of principles from the roots and heartwood of Caesalpinia sappan on antigen-induced β-hexosaminidase release,” Phytotherapy Research, vol. 23, no. 7, pp. 1028–1031, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. H.-I. Moon, I.-M. Chung, S.-H. Seo, and E.-Y. Kang, “Protective effects of 3'-deoxy-4-omethylepisappanol from Caesalpinia sappan against glutamate-induced neurotoxicity in primary cultured rat cortical cells,” Phytotherapy Research, vol. 24, no. 3, pp. 463–465, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. K. Moon, “Drugs from Caesalpinia,” Ger Offen, vol. DE 3511609 A1 19861002, 1986.
  12. J. Xu, T. Shi, S. Zhang, S. Guo, L. Qiao, and K. Li, “Manufacture and application of water extract of caesalpinia sappan for treating ascites tumor and leukemia,” Faming Zhuanli Shenqing, vol. CN 101411739 A 20090422, 2009.
  13. W. H. Park, M. J. Lee, J. Y. Kim, and Y. H. Jung, “Pharmaceutical composition containing Caesalpinia sappan extract for preventing and treating arteriosclerosis,” Republic of Korean Kongkae Taeho Kongbo, vol. KR 2008076343 A 20080820, 2008.
  14. J. Hu, X. Yan, W. Wang, H. Wu, L. Hua, and L. Du, “Antioxidant activity in vitro of three constituents from Caesalpinia sappan L,” Tsinghua Science and Technology, vol. 13, no. 4, pp. 474–479, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. V. S. Srillakshmi, P. Vijayan, P. V. Raj, S. A. Dhanaraj, and H. R. Chandrashekhar, “Hepatoprotective properties of Caesalpinia sappan Linn. heartwood on carbon tetrachloride induced toxicity,” Indian Journal of Experimental Biology, vol. 48, no. 9, pp. 905–910, 2010. View at Google Scholar · View at Scopus
  16. K. Sarumathy, T. Vijay, S. Palani, K. Sakthivel, and M. S. D. Rajan, “Antioxidant and hepatoprotective effects of Caesalpinia sappan against acetaminophen-induced hepatotoxicity in rats,” International Journal of Pharmacology and Therapeutics, vol. 1, pp. 19–31, 2011. View at Google Scholar
  17. L. S. R. R Pramely, “Prediction of biological activity spectra of a few phytoconstituents of Azadirachta indicia A. Juss,” Journal of Biochemical Technology, vol. 3, pp. 375–379, 2012. View at Google Scholar
  18. A. Lagunin, A. Stepanchikova, D. Filimonov, and V. Poroikov, “PASS: prediction of activity spectra for biologically active substances,” Bioinformatics, vol. 16, no. 8, pp. 747–748, 2000. View at Google Scholar · View at Scopus
  19. T. Ueki, Y. Kaneda, H. Tsutsui et al., “Hepatocyte growth factor gene therapy of liver cirrhosis in rats,” Nature Medicine, vol. 5, no. 2, pp. 226–230, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. F. E. Koehn and G. T. Carter, “The evolving role of natural products in drug discovery,” Nature Reviews Drug Discovery, vol. 4, no. 3, pp. 206–220, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. Guide for the Care and Use of Laboratory Animals, The National Academies Press, 1996.
  22. X.-Y. Zhao, B.-E. Wang, X.-M. Li, and T.-L. Wang, “Newly proposed fibrosis staging criterion for assessing carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents,” Pathology International, vol. 58, no. 9, pp. 580–588, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Kuzu, K. Metin, A. F. Dagli et al., “Protective role of genistein in acute liver damage induced by carbon tetrachloride,” Mediators of Inflammation, vol. 2007, Article ID 36381, 6 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. A. Amali, R. D. Rekha, C. J.-F. Lin et al., “Thioacetamide induced liver damage in zebrafish embryo as a disease model for steatohepatitis,” Journal of Biomedical Science, vol. 13, no. 2, pp. 225–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Okazaki, Y. Ninomiya, T. Kyuichi, and S. I. Friedman, Extracellular Matrix and the Liver: Approach to Gene Therapy, Academic Press, 2003.
  26. F. A. Kadir, F. Othman, M. A. Abdulla, F. Hussan, and P. Hassandarvish, “Effect of Tinospora crispa on thioacetamide-induced liver cirrhosis in rats,” Indian Journal of Pharmacology, vol. 43, no. 1, pp. 64–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Spira and I. Raw, “The effect of thioacetamide on the activity and expression of cytosolic rat liver glutathione-S-transferase,” Molecular and Cellular Biochemistry, vol. 211, no. 1-2, pp. 103–110, 2000. View at Google Scholar · View at Scopus
  28. R. Bruck, H. Aeed, H. Shirin et al., “The hydroxyl radical scavengers dimethylsulfoxide and dimethylthiourea protect rats against thioacetamide-induced fulminant hepatic failure,” Journal of Hepatology, vol. 31, no. 1, pp. 27–38, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. G. D. W. Derek, Ed., Systemic Pathology: Liver, Biliary Tract and Exocrine Pancreas, Churchill Livingstone, 1994.
  30. K. Kropacova, E. Misurova, and E. H. H, “Protective and therapeutic effect of silymarin on the development of latent liver damage,” Radiatsionnaia Biologiia, Radioecologiia, vol. 38, pp. 411–415, 1998. View at Google Scholar
  31. S. Luper, “A review of plants used in the treatment of Liver disease: part 1,” Alternative Medicine Review, vol. 3, no. 6, pp. 410–421, 1998. View at Google Scholar · View at Scopus
  32. K. H. Janbaz and A. H. Gilani, “Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents,” Fitoterapia, vol. 71, no. 1, pp. 25–33, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. A. A. Nanji, K. Jokelainen, G. L. Tipoe, A. Rahemtulla, P. Thomas, and A. J. Dannenberg, “Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-κB-dependent genes,” American Journal of Physiology, vol. 284, no. 2, pp. G321–G327, 2003. View at Google Scholar · View at Scopus
  34. M. Agarwal, V. K. Srivastava, K. K. Saxena, and A. Kumar, “Hepatoprotective activity of Beta vulgaris against CCl4-induced hepatic injury in rats,” Fitoterapia, vol. 77, no. 2, pp. 91–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. A. Lagunin, O. A. Gomazkov, D. A. Filimonov et al., “Computer-aided selection of potential antihypertensive compounds with dual mechanism of action,” Journal of Medicinal Chemistry, vol. 46, no. 15, pp. 3326–3332, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. A. V. P, “Computer-assisted mechanism-of action analysis of large databases, including 250,000 open NCI database compounds,” Plant Resources, vol. 34, pp. 61–64, 1998. View at Google Scholar
  37. C. K. Moon, “Drugs from Caesalpinia,” Ger Offen, vol. DE 3511609 A1 19861002, 1986.
  38. W. H. Park, M. J. Lee, J. Y. Kim, and Y. H. Jung, “Pharmaceutical composition containing Caesalpinia sappan extract for preventing and treating arteriosclerosis,” Repubublic of Korean Kongkae Taeho Kongbo, vol. KR 2008076343 A 20080820, 2008.
  39. H. L. Reeves and S. L. Friedman, “Activation of hepatic stellate cells—a key issue in liver fibrosis,” Frontiers in Bioscience, vol. 7, pp. 808–826, 2002. View at Google Scholar · View at Scopus
  40. E. Yu, G. Choe, G. Gong, and I. Lee, “Expression of alpha-smooth muscle actin in liver diseases,” Journal of Korean medical science, vol. 8, no. 5, pp. 367–373, 1993. View at Google Scholar · View at Scopus
  41. N. Sanderson, V. Factor, P. Nagy et al., “Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 7, pp. 2572–2576, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Poli, “Pathogenesis of liver fibrosis: role of oxidative stress,” Molecular Aspects of Medicine, vol. 21, no. 3, pp. 49–98, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. B.-J. Zhang, D. Xu, Y. Guo, J. Ping, L.-B. Chen, and H. Wang, “Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors,” Clinical and Experimental Pharmacology and Physiology, vol. 35, no. 3, pp. 303–309, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. J. E. Klaunig, L. M. Kamendulis, and B. A. Hocevar, “Oxidative stress and oxidative damage in carcinogenesis,” Toxicologic Pathology, vol. 38, no. 1, pp. 96–109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Y. Park, H. W. Shin, K. B. Lee, M.-J. Lee, and J.-J. Jang, “Differential expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in thioacetamide-induced chronic liver injury,” Journal of Korean Medical Science, vol. 25, no. 4, pp. 570–576, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Malhi, G. J. Gores, and J. J. Lemasters, “Apoptosis and necrosis in the liver: a tale of two deaths?” Hepatology, vol. 43, no. 2, pp. S31–S44, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. S. M. Salama, M. A. Abdulla, A. S. AlRashdi, S. Ismail, S. S. Alkiyumi, and S. Golbabapour, “Hepatoprotective effect of ethanolic extract of Curcuma longa on thioacetamide induced liver cirrhosis in rats,” BMC Complementary and Alternative Medicine, vol. 13, article 56, 2013. View at Google Scholar
  48. D. Abraham, M. Ponticos, and H. Nagase, “Connective tissue remodelling: cross-talk between endothelins and matrix metalloproteinases,” Current Vascular Pharmacology, vol. 3, no. 4, pp. 369–379, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Wang, J.-S. Zhang, G.-C. Huang, Q. Cheng, and Z.-H. Zhao, “Effects of adrenomedullin gene overexpression on biological behavior of hepatic stellate cells,” World Journal of Gastroenterology, vol. 11, no. 23, pp. 3549–3553, 2005. View at Google Scholar · View at Scopus
  50. C. J. Parsons, B. U. Bradford, C. Q. Pan et al., “Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats,” Hepatology, vol. 40, no. 5, pp. 1106–1115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. G.-F. Shi and Q. Li, “Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo,” World Journal of Gastroenterology, vol. 11, no. 2, pp. 268–271, 2005. View at Google Scholar · View at Scopus
  52. J. H. An, J. Seong, H. Oh, W. Kim, K. H. Han, and Y. H. Paik, “Protein expression profiles in a rat cirrhotic model induced by thioacetamide,” The Korean journal of hepatology, vol. 12, no. 1, pp. 93–102, 2006. View at Google Scholar · View at Scopus
  53. R. Bruck, M. Ashkenazi, S. Weiss et al., “Prevention of liver cirrhosis in rats by curcumin,” Liver International, vol. 27, no. 3, pp. 373–383, 2007. View at Publisher · View at Google Scholar · View at Scopus